Bitcoin
74451.13
-215.49
-0.29%
Crude Oil
95.43
+0.15
+0.16%
Gold
5011.6
+4.2
+0.08%
Copper
5.77
-0.07
-1.14%
Silver
79.92
-1.05
-1.32%
Dow Jones
46946.42
+387.94
+0.83%
SP500
6719.39
+18.38
+0.27%
NASDAQ
22374.18
+268.82
+1.2%

CheckMan Stock Market Overview

Trending Stocks

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
37.43
+100.00%
Top Gainers
171,671
Top Gainers
42.1
+100.00%
Top Gainers
294,691
Top Gainers
220
+100.00%
Top Gainers
36,115,481
Top Gainers
25.42
+100.00%
Top Gainers
616,311
Top Gainers
319.8
+100.00%
Top Gainers
3,338,095
Top Gainers
3.45
+99.00%
Top Gainers
162,203
Top Gainers
10.49
+41.85%
Top Gainers
170,650
Top Gainers
8.62
+32.25%
Top Gainers
2,019,219
Top Gainers
13.6
+31.84%
Top Gainers
3,359,597
Top Gainers
6.75
+29.04%
Top Gainers
379,114
Top Gainers

Red List

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
263
-900.00%
Top Loosers
593,289
Top Loosers
261
-391.95%
Top Loosers
926,457
Top Loosers
1.3151
-221.65%
Top Loosers
588,675
Top Loosers
8.82
-161.56%
Top Loosers
215,283
Top Loosers
6
-64.00%
Top Loosers
1,410,385
Top Loosers
1.06
-53.77%
Top Loosers
749,686
Top Loosers
1.2386
-50.98%
Top Loosers
334,377
Top Loosers
1.61
-43.48%
Top Loosers
5,284,170
Top Loosers
328
-42.68%
Top Loosers
319,962
Top Loosers
3.54
-37.01%
Top Loosers
532,567
Top Loosers

In Today's Headlines

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages GSI Technology Inc. Investors to Inquire About Securities Class Action Investigation - GSIT
02:30
17 Mar 2026
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages GSI Technology Inc. Investors to Inquire About Securities Class Action Investigation - GSIT

New York, New York--(Newsfile Corp. - March 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GSI Technology Inc. (NASDAQ: GSIT) resulting from allegations that GSI Technology may have issued materially misleading business information to the investing public. SO WHAT: If you purchased GSI Technology securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

The Moon Group Founder Carl Runefelt Makes Ferrari Challenge Debut at Circuit Paul Ricard
02:29
17 Mar 2026
The Moon Group Founder Carl Runefelt Makes Ferrari Challenge Debut at Circuit Paul Ricard

LE CASTELLET, France, March 17, 2026 (GLOBE NEWSWIRE) -- Key Highlights Carl Runefelt (“Carl Moon”) made his Ferrari Challenge debut at Circuit Paul Ricard in Le Castellet, France Entered the weekend as the only rookie on the grid Faced challenging weather conditions including strong wind and rain during qualifying and racing Delivered strong defensive driving and intense mid-field battles throughout the races Finished P6 and P7, securing valuable championship points in his first race weekend Used the event to reveal his main sponsor WEEX, a leading cryptocurrency exchange Carl is widely known from 'The Moon Show,' reaching over 5 million followers across social media The Moon Group, a Web3 and blockchain incubation platform, announced the introduction of its Founder, Carl Runefelt, also known as Carl Moon into racing. The development marked a notable milestone as the worlds of cryptocurrency and motorsport came together this weekend when he made his debut in the Ferrari Challenge at the legendary Circuit Paul Ricard in Le Castellet, France.

Is UBER stock a buy at 22x forward earnings? The Nvidia catalyst explained
02:25
17 Mar 2026
Is UBER stock a buy at 22x forward earnings? The Nvidia catalyst explained

Uber Technologies (NYSE: UBER) is extending gains today as investors react to its landmark partnership with Nvidia (NASDAQ: NVDA) that strengthens its long-term autonomous vehicle roadmap. The collaboration integrates Nvidia's DRIVE Hyperion architecture and “Alpamayo” AI model into UBER's global network, enhancing simulation, routing, and fleet management capabilities across its mobility ecosystem.

Stanley Black & Decker, Inc. (SWK) Presents at JPMorgan Industrials Conference 2026 Transcript
02:22
17 Mar 2026
Stanley Black & Decker, Inc. (SWK) Presents at JPMorgan Industrials Conference 2026 Transcript

Stanley Black & Decker, Inc. (SWK) Presents at JPMorgan Industrials Conference 2026 Transcript

Securities Fraud Investigation Into Tennant Company (TNC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
02:21
17 Mar 2026
Securities Fraud Investigation Into Tennant Company (TNC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Tennant Company (“Tennant” or the “Company”) (NYSE: TNC) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON TENNANT COMPANY (TNC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On February 23, 2026, Tennant released its full year 2025 financial results,.

Software firms are on the defensive as AI accelerates
02:20
17 Mar 2026
Software firms are on the defensive as AI accelerates

CNBC's Leslie Picker reports from Thoma Bravo's annual meeting where software companies explain how they are pivoting as AI disrupts the industry.

KROS Stock: What to Know About Rinvatercept in DMD
02:20
17 Mar 2026
KROS Stock: What to Know About Rinvatercept in DMD

Keros advances rinvatercept in DMD with orphan status, fresh phase I data, and a planned Q2 2026 phase II start driving its near-term execution story.

KROS: Is the Discount Book Value a Value Trap?
02:20
17 Mar 2026
KROS: Is the Discount Book Value a Value Trap?

Keros posts a 2025 revenue surge from Takeda licensing, but no product sales and volatile drivers leave investors weighing a discounted valuation against execution risk.

KROS Pipeline Catalysts: DMD Phase II and ALS Plans for 2026
02:20
17 Mar 2026
KROS Pipeline Catalysts: DMD Phase II and ALS Plans for 2026

Keros lines up 2026 catalysts with rinvatercept at the core, including a Q2 DMD phase II start and ALS regulatory plans as execution shifts into focus.

RGA Offers Upside on Strong Growth Prospects - Buy or Hold the Stock?
02:20
17 Mar 2026
RGA Offers Upside on Strong Growth Prospects - Buy or Hold the Stock?

Reinsurance Group of America gains momentum on strong earnings growth, capital strength and deal activity, with analysts seeing 25% upside.